Bin Sabbar, N. S., Alowirdi, F. S., Basakran, F. A., Al-Badr, L. A., Assiri, R. A., Alshahrani, W. A., Althubaiti, A., & Damlaj, M. (2019). Addition of rituximab to hyper-CVAD improves overall survival in newly diagnosed Burkitt leukemia/lymphoma from the Middle East and North Africa region. International Journal Of Community Medicine And Public Health, 6(10), 4199–4203. https://doi.org/10.18203/2394-6040.ijcmph20194475